Short of some American company completely buying us out and ending the ride for everyone here, it would be smart to licence the product to any pharma company in China/SK/Japan who has the money to do so. We're all ok it seems with licensing this to some American outfit, but I don't see why we need to give anyone there a worldwide monopoly on it if we still retain control of the end result. Bring on the partners.
Ann: Oncolytic Virotherapy CF33 Patent Granted in China, page-108
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.004(8.16%) |
Mkt cap ! $394.1M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.5¢ | 4.8¢ | $1.798M | 35.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 2193808 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 605064 | 3 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |